GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Epo | increases expression | EXP | | 6480464 | CTD | Deferoxamine deficiency results in increased expression of EPO mRNA; Deferoxamine results in increased expression of EPO mRNA | PMID:10756076 | Epo | increases stability | EXP | | 6480464 | CTD | Deferoxamine deficiency results in increased stability of EPO mRNA | PMID:10756076 | Epo | increases expression | ISO | Epo (Rattus norvegicus) | 6480464 | CTD | Deferoxamine results in increased expression of EPO mRNA; Deferoxamine results in increased expression of EPO protein | PMID:10559391 PMID:21558026 PMID:9927288 | Epo | increases expression | ISO | EPO (Homo sapiens) | 6480464 | CTD | Deferoxamine results in increased expression of EPO mRNA | PMID:10699462 | Epo | multiple interactions | ISO | Epo (Rattus norvegicus) | 6480464 | CTD | Deferoxamine inhibits the reaction [Reactive Oxygen Species results in decreased expression of EPO protein] | PMID:9927288 | |
Go Back to source page | Continue to Ontology report |